COVID-19 Reshapes Oman Pharma Security
The article focused on the Sultanate of Oman's efforts to strengthen national pharmaceutical security by establishing specialized industrial clusters in pharmaceutical manufacturing and medical devices. This is part of an long-term strategy to reduce dependence on imports and ensure the sustainability of supply chains. After the outbreak of the COVID-19 pandemic, which highlighted the necessity of local production capability, the Sultanate developed an industrial system now comprising 20 factories producing medicines and medical supplies. There are plans to establish integrated industrial complexes that combine manufacturing, storage, and distribution within a single ecosystem. Additionally, the value of the Ministry of Health's purchases from domestic companies has increased by 150%, along with increased investments in new factories, and government initiatives to build extensive industrial infrastructure to achieve greater independence in essential pharmaceutical products. The goal is to reduce risks and enhance national health security.
Notice: This Is an AI-Generated Summary
Comments (0)